Other

GSK sees earnings rise amid good demand for vaccines

Pharmaceutical company GlaxoSmithKline says its net profit rose 50 percent in the third quarter to 808 million pounds ($986 million) thanks in part to strong sales of its vaccine products.

Medications

Charity scores small win in Hep C drug battle

A medical charity scored a small victory Wednesday in its bid to break a US pharma giant's hold on an eye-wateringly expensive Hepatitis C drug when a European body partially revoked the firm's patent.

Cancer

Approval of test to diagnose adrenal cancer

A new analytical test has been launched in the UK that provides sensitive, specific and efficient predictive analysis of a rare form of cancer from a simple urine sample. The ACC steroid analysis service will be marketed ...

HIV & AIDS

HIV diagnostic kit wins European inventors prize

A rapid HIV diagnostic kit for developing nations, designed by Cambridge University researcher Helen Lee, won the Popular Prize at the European Inventor Awards on Thursday.

Diabetes

One step closer to curing diabetes

A human cell line genetically engineered to produce, store and release insulin in response to blood sugar levels in the human body could eliminate the need for daily injections for insulin-reliant diabetics.

Medications

Gilead wins India patent for blockbuster Hepatitis drug

India has granted a patent to US pharmaceutical giant Gilead for a blockbuster Hepatitis C drug, in a U-turn activists said could potentially stop affordable copies reaching millions of people in other countries.

Medications

Jury finds for Merck in hepatitis drug fight with Gilead

A federal jury in California has ruled in favor of drugmaker Merck & Co. in a high-stakes lawsuit against rival Gilead Sciences Inc. over patents for lucrative new drugs that rapidly cure hepatitis C.

page 2 from 14